Navigation Links
Senior Management of NeoStem and Its Subsidiaries Invited to Speak at Seventh International Conference on Cell Therapy for Cardiovascular Disease
Date:1/23/2012

shed A. Quyyumi, MD, FRCP, FACC, principal investigator of the PreSERVE AMI Phase 2 trial and Professor of Medicine and Cardiology at Emory University, will speak on a panel entitled "Early and Next Phase Studies" within a session entitled "Acute Injury: STEMI and NSTEMI".
  • From 7:30 to 8:30 AM on Friday, January 27, Robert A. Preti, PhD, President of Progenitor Cell Therapy will speak as part of Industry Session III entitled "Focus on Procedure, Systems Management, and Advanced Technologies."

    • Dr. Pecora said, "As a presenter at the first industry session, I look forward to informing industry leaders about the PreSERVE Phase 2 clinical trial for AMI which is now open for enrollment and may provide data readout 18 months from the first patient enrollment, as well as discussing the recent patent issued to use the Amorcyte technology beyond cardiovascular disease." 

    Dr. Robin L. Smith, Chairman and CEO of NeoStem, said, "This conference represents validation that the development of cell therapies for diseases outside of bone marrow transplantation is progressing as represented by their current clinical data. Our acquisition of Amorcyte last year has positioned NeoStem to be a leader in the cell therapy cardiovascular space. We are excited to be a part of the developing science represented by this important conference and share our expertise represented by the progress with Amorcyte and our capabilities to assist the field with the manufacturing services of PCT."

    About the Cardiovascular Research Foundation According to the Cardiovascular Research Foundation, their role in interventional cardiovascular medicine is unique: conducting research on therapies, pharmacology, and devices during the earliest stages of development, confirming safety and efficacy in
    '/>"/>

    SOURCE NeoStem, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    0

    GOOD

    Page: 1 2 3 4

    Related biology technology :

    1. Darius Naigamwalla Appointed Senior Vice President and Head of the Brand Management Practice at Campbell Alliance
    2. SCAN Health Plan Offers Seniors Five Tips to Prepare for Surgery
    3. Inc. Magazine Names Senior Whole Health the Number One Fastest-Growing Private Company in US
    4. Angiotech Announces Extension of the Expiration Date of its Tender Offer for Senior Floating Rate Notes Due 2013 and 7.75% Senior Subordinated Notes Due 2014
    5. Micromet, Inc. Appoints Barclay Phillips as Senior Vice President and Chief Financial Officer
    6. Anesiva Announces Appointment of William Houghton, M.D. as Senior Vice President and Chief Medical Officer
    7. On-Line Medicare Advisor Saves Seniors Time, Hassle and Money
    8. Simcere Pharmaceutical Group Announces Two Senior Promotions and Appointment of New Vice President of Human Resources
    9. ACORN Contract Research Organization Appoints Tara Webb as Senior Director of CRO Business Development
    10. Orexigen(R) Therapeutics Appoints Dennis Kim, M.D., as Senior Vice President, Head of Obesity and Metabolic Disorders
    11. Cell Therapeutics, Inc. Announces Single Institutional Investor Purchases $14.2 Million of Senior Convertible Notes
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/23/2013)... Auburn, MA (PRWEB) May 23, 2013 ... one inch wide and provide 15 mm travel ... nanometers. The small dimensions make these new ... in confined spaces. A vacuum rated version is ... Datasheet:, Drawings, specifications and datasheets can be found ...
    (Date:5/23/2013)... 23, 2013 On April 19th the ... supermarkets to search for the growing antibiotic resistant bacteria ... from a year long study were released late last ... specifically meats, over previous years. For those suffering from ... of antibiotic resistant bacteria in food, may eventually help ...
    (Date:5/23/2013)... 23, 2013  Verenium Corporation (Nasdaq: VRNM ... development and commercialization of high-performance enzymes, today announced that ... will present at two upcoming conferences. (Logo: ... at the Second Annual Marcum LLP Microcap Conference on ... in New York City.  The presentation is scheduled to ...
    (Date:5/23/2013)... 2013 Bed bugs already cost Alton Housing ... still ongoing, a report from kmov.com suggested that the said ... bug treatment. Meanwhile, to be of help, My Cleaning Products ... bed bug exterminator service. , The report, which ... so far spent $35,000 for bed bug elimination, ...
    Breaking Biology Technology:Precision Positioning System Uses Miniaturezed Piezo Linear Motor: LPS-24 Linear Stage by PI 2Acne Cream, Probiotic Action Shares News on How Some Food may Breed Acne Causing Bacteria 2Verenium To Present At Two Upcoming Conferences 2Verenium To Present At Two Upcoming Conferences 3Bed Bug Exterminator Service Could Cost AHA $250K, My Cleaning Products Gives Tips How to Save Apartments from Costly Bed Bug Treatment 2
    ... HAVEN, Conn., Dec. 17 Prometheus Research, a leading ... been awarded a $136,500 National Science Foundation grant to ... be installed and configured at low cost, with minimal ... Science Foundation (NSF) awarded the grant to Prometheus Research ...
    ... N.J., Dec. 17 Osteotech, Inc. (Nasdaq: OSTE ), ... regenerative healing, announced today that it has submitted a 510(k) ... to obtain marketing clearance for the use of its Duratech(TM) ... outermost membrane surrounding the brain) in various cranial surgical procedures. ...
    ... , ... continued to rise the U.S. in November, even as the overall unemployment rate edged down ... ... was a relatively good month for pharmaceutical job losses - which is to ...
    Cached Biology Technology:Prometheus Research Awarded National Science Foundation Grant for Easy to Use, Web-Enabled Database Software 2Prometheus Research Awarded National Science Foundation Grant for Easy to Use, Web-Enabled Database Software 3Osteotech Submits 510(k) Application to FDA for Clearance of its Duratech(TM) BioRegeneration Matrix 2Osteotech Submits 510(k) Application to FDA for Clearance of its Duratech(TM) BioRegeneration Matrix 3The MedZilla Report for November 2009 - Healthcare Employment Up, And No Major Bad News for Pharma, Either 2The MedZilla Report for November 2009 - Healthcare Employment Up, And No Major Bad News for Pharma, Either 3
    (Date:5/21/2013)... that a class of pharmaceuticals can both prevent and ... known as "TSPO ligands," are currently used for certain ... of TSPO ligand in young adult mice when pathology ... when pathology was quite severe," said lead researcher Christian ... ligand reduced measures of pathology and improved behavior at ...
    (Date:5/21/2013)... Mo. Cancers of all types become most deadly ... Once cancer has reached this stage, it becomes very ... tumors that can develop. Now, researchers at the University ... nanoparticles that target lymphoma tumor cells wherever they may ... of oncology in the MU College of Veterinary Medicine, ...
    (Date:5/21/2013)... Widely available in pharmacies and health stores, phosphatidylserine ... oysters, and soy. Proven to improve cognition and ... older people experiencing memory impairment. Now a team ... Bochner of Tel Aviv University,s Department of ... same supplement improves the functioning of genes involved ...
    Breaking Biology News(10 mins):Drugs found to both prevent and treat Alzheimer's disease in mice 2MU researchers develop radioactive nanoparticles that target cancer cells 2Common food supplement fights degenerative brain disorders 2
    ... theory of everything," proposed by a surfing physicist in ... Skip Garibaldi. Garibaldi did the math to ... as E8. The resulting paper ( http://arxiv.org/abs/0905.2658 ), ... Texas, will appear in an upcoming issue of ...
    ... This release is available in German ... the Infrafrontier project, funded by the European Union, has been ... Austria, France and Italy. The new partners will join the ... up an international research infrastructure to improve open access to ...
    ... genetic material from only one of their parents has been ... be published March 25 in the journal Nature, ... desirable traits. The discovery came out of a chance ... off as an error. "We were doing completely ,blue ...
    Cached Biology News:Research concludes there is no 'simple theory of everything' inside the enigmatic E8 2Biomedical research infrastructure goes global: EU consortium Infrafrontier has new partners 2Chance discovery leads to plant breeding breakthrough 2Chance discovery leads to plant breeding breakthrough 3
    ... for covering tissue sections and cell preparations immunohistochemically ... insoluble end products. UltraMount Plus can ... or AEC that require an aqueous mounting medium, ... No heating is required prior to use. This ...
    ... to JAK2 (phospho Y1007) ( Abpromise ... Antigen: Synthesized phosphopeptide ... phosphorylation site of tyrosine 1007 (K-E-Y ... Gene ID: 3717 ...
    Rabbit polyclonal to JNK1 (phospho T183 + Y185) ( Abpromise for all tested applications). entrezGeneID: 5599 SwissProtID: P45983...
    ... Abpromise for all tested applications). ... to KLH derived from within residues 400 ... acid sequence is proprietary)(Peptide available as ... ID: 55693 Swiss ...
    Biology Products: